Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China flag China · Delayed Price · Currency is CNY
26.20
+0.01 (0.04%)
At close: Apr 18, 2025, 2:57 PM CST

SHE:301089 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2014 - 2018
Period Ending
Sep '24 Dec '23 Jan '23 Jan '22 Dec '20 Jan '20 2015 - 2019
Cash & Equivalents
207.43148.55307.09284.22158.22103.76
Upgrade
Trading Asset Securities
150.24190.7240.16220.62--
Upgrade
Cash & Short-Term Investments
357.67339.26547.25504.84158.22103.76
Upgrade
Cash Growth
1.66%-38.01%8.40%219.08%52.49%-40.74%
Upgrade
Accounts Receivable
153.58235.3205.41103.5892.1160.42
Upgrade
Other Receivables
0.1512.5713.660.620.282.41
Upgrade
Receivables
153.73247.86219.07104.292.3962.84
Upgrade
Inventory
162.79204.11241.14167.08159.9130.93
Upgrade
Other Current Assets
24.1330.946.5420.644.4112.77
Upgrade
Total Current Assets
698.32822.171,014796.76414.91310.29
Upgrade
Property, Plant & Equipment
828.36809.38610.26449.11415.14302.74
Upgrade
Long-Term Investments
8.978.3710.8612.5415.6221.83
Upgrade
Other Intangible Assets
81.2984.0484.2684.5671.0273.04
Upgrade
Long-Term Accounts Receivable
-----3.09
Upgrade
Long-Term Deferred Tax Assets
71.4263.7170.366.517.667.95
Upgrade
Long-Term Deferred Charges
2.682.71.862.338.014.08
Upgrade
Other Long-Term Assets
55.5548.6251.6441.914.1116.83
Upgrade
Total Assets
1,7471,8391,8431,394946.48739.85
Upgrade
Accounts Payable
114.64152.55158.58162.94213.38137.58
Upgrade
Accrued Expenses
8.3524.5869.0917.5121.0816.25
Upgrade
Short-Term Debt
--40.0364.5147.41133.07
Upgrade
Current Portion of Leases
---4.9118.4419.92
Upgrade
Current Income Taxes Payable
2.8066.051.312.370.05
Upgrade
Current Unearned Revenue
0.855.4871.892.915.664.74
Upgrade
Other Current Liabilities
11.8111.918.320.532.1510.47
Upgrade
Total Current Liabilities
138.45194.51423.96254.6420.5322.08
Upgrade
Long-Term Debt
----4.8-
Upgrade
Long-Term Leases
----4.9123.34
Upgrade
Long-Term Unearned Revenue
33.7535.1738.3140.423.577.75
Upgrade
Long-Term Deferred Tax Liabilities
5.416.044.611.361.833.02
Upgrade
Other Long-Term Liabilities
-----0.55
Upgrade
Total Liabilities
177.61235.72466.89296.35455.61356.74
Upgrade
Common Stock
126.54126.5412612694.594.5
Upgrade
Additional Paid-In Capital
621.11621.11585.3578.5466.7766.77
Upgrade
Retained Earnings
819.89854.18661.5387.57321.86209.06
Upgrade
Comprehensive Income & Other
1.441.443.575.257.7512.79
Upgrade
Total Common Equity
1,5691,6031,3761,097490.87383.11
Upgrade
Shareholders' Equity
1,5691,6031,3761,097490.87383.11
Upgrade
Total Liabilities & Equity
1,7471,8391,8431,394946.48739.85
Upgrade
Total Debt
--40.0369.41175.56176.33
Upgrade
Net Cash (Debt)
357.67339.26507.22435.43-17.34-72.57
Upgrade
Net Cash Growth
1.66%-33.11%16.49%---
Upgrade
Net Cash Per Share
2.732.694.024.37-0.18-0.77
Upgrade
Filing Date Shares Outstanding
126.54126.5412612694.594.5
Upgrade
Total Common Shares Outstanding
126.54126.5412612694.594.5
Upgrade
Working Capital
559.87627.66590.04542.16-5.59-11.78
Upgrade
Book Value Per Share
12.4012.6710.928.715.194.05
Upgrade
Tangible Book Value
1,4881,5191,2921,013419.85310.08
Upgrade
Tangible Book Value Per Share
11.7612.0110.258.044.443.28
Upgrade
Buildings
-267.66257.26210.62101.891.69
Upgrade
Machinery
-382.3354.84301.65195.05117.2
Upgrade
Construction In Progress
-331.03130.4835.59266.05173.63
Upgrade
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.